A new study has identified pathogenic variants in WNT9B as significant risk factors for hereditary prostate cancer. Read more ...

The world’s first chikungunya vaccine, developed by French pharmaceutical firm Valneva SE, has been approved in the UK by the ...

Vitamin D deficiency is strongly associated with an increased risk of severe acute exacerbations in patients with chronic ...

Study finds that ultrafast MRI-based radiomics model performs just as well as standard MRI in classifying breast cancer ...

A novel biomarker signature can classify pain sensitivity, offering potential for early intervention and improved chronic ...

A UK study finds detectable antibodies reduce COVID-19 infection and severity in immunosuppressed individuals, highlighting ...

AHA’s 2025 report reveals rising heart disease and stroke burden, stressing prevention, health equity, and clinical action.

A study revealed that maternal allergies and the season of an infant’s birth influence the breast milk microbiome, impacting ...

Exagamglogene autotemcel (exa-cel) gene therapy offers a potential cure for severe sickle cell disease, now available on NHS.

Immunotherapy has shown a 27% reduction in mortality for patients with limited-stage small cell lung cancer, based on Phase ...

Mayo Clinic advances AI in radiology and genomics, enhancing diagnostics and treatment personalisation with Microsoft and ...

Nasal microbiota transplantation could revolutionise the treatment of chronic rhinosinusitis and respiratory tract infections ...